Singapore - COPD hospitalizations are at an all-time high. The 30-day readmission rate for patients ranges from 20-39 pe...
Bringing in much needed relief for millions of gastroenteropancreatic neuroendocrine cancer patients, the Japanese regul...
Singpaore: In a bid to strengthen trade between two countries, the Taiwan Pharmaceutical Manufacturer’s Associatio...
Singapore: The European Commission has approved Xtandi (enzalutamide) capsules for the treatment of men with metastatic ...
Singapore: Sanofi's India unit and Carlyle group are in talks to buy the domestic drug formulation business of Indian dr...
Singapore: US Food and Drug Administration has raised alarm for Gilead Science's cancer medicine Zydelig (idelalisib) du...
Singapore: On July 9, 2012, the Generic Drug User Fee Amendments of 2012 (GDUFA) was enacted by the US. The Food and Dru...
Mumbai: Mumbai-based pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received approval for its Norgestimate ...
Singapore: The US Food and Drug Administration (FDA) has given its finally approval to India's Sun Pharmaceutical Indust...
Singapore: Miffed at Indian government's move to slash prices of essential medicines through the new drug pricing policy...
New Delhi: Ahead of the Drug Price Control Order (DPCO) to revise drug prices that came into effect on July 29, medicine...
Singapore: US Food and Drug Administration has approved the first generic versions of Cymbalta (duloxetine delayed-relea...
Singapore: Japan's drug major Takeda Pharmaceutical has said that they are set to finish the early stage human studies o...
Daiichi Sankyo Company Limited has announced that on Friday, June 19, its generics subsidiary, Daiichi Sankyo Espha, wil...
Singapore: In a recent move, the US Food and Drug Administration (FDA) has decided to extend the timeline for granting t...
Singapore: The US Food and Drug Administration has approved generic versions of the blood thinning drug Plavix (clopidog...
Singapore: The US FDA released a set of further current good manufacturing practices (cGMP) violations that have been no...
Singapore: Taiwan based TWi Pharmaceuticals, has launched generic version of Par Pharmaceutical's Megace ES (megestrol a...
